Foamix Pharmaceuticals Ltd. said its experimental acne treatment failed to meet one of two main goals in a late-stage study, pushing its shares down about 42 percent.
- 2015 Annual Report: Top 10 Pipelines 11,866 views
- 2016 Annual Report: Top 10 Pipelines 11,200 views
- Celgene Snaps Up Merck & Co.’s Giant Complex in New Jersey 9,600 views
- 2015 Annual Report: Top 100 Biotechnology Companies – The Acquisition Game 3,900 views